Insulin NovoNordisk NovoRapid Penfill, Injektionslösung

7680550460030 CH-55046 Injektionslösung
Insulin NovoNordisk NovoRapid Penfill, Injektionslösung
Insulin NovoNordisk NovoRapid Penfill, Injektionslösung
Insulin NovoNordisk NovoRapid Penfill, Injektionslösung
1 / 3
google

Article details

Package size
5 x 3
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/12/2022
Patient information leaflet
Français
19/12/2022
Patient information leaflet
Italien
19/12/2022

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 U Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.9 MG Substance HBESI

Reimbursement information

Public price
CHF 52.50
Specialties list
Yes
Generic
No
SL addition date: 01/01/2000

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
55046
Drug name
Insulin NovoNordisk NovoRapid Penfill, Injektionslösung
Galenic form
LSILP
ATC Code
A10AB05
Authorization status
Z
Dispensing category
B
First authorization
15/06/1999
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Package details

Description (FR)
INSULINE NovoRapid Penfill 5 cartouche 3 ml
Description (DE)
INSULIN NovoRapid Penfill 5 Patrone 3 ml
Market launch
15/06/1999
Narcotic (BTM)
No